Literature DB >> 28012486

Safety management of treatment with nintedanib in clinical practice of IPF.

Arata Azuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28012486     DOI： 10.1016/j.resinv.2016.12.001

Source DB:  PubMed          Journal:  Respir Investig        ISSN： 2212-5345


× No keyword cloud information.
  1 in total

1.  Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis.

Authors:  Satoshi Ikeda; Akimasa Sekine; Tomohisa Baba; Yumie Yamanaka; Shinko Sadoyama; Hideaki Yamakawa; Tsuneyuki Oda; Ryo Okuda; Hideya Kitamura; Koji Okudela; Tae Iwasawa; Kenichi Ohashi; Tamiko Takemura; Takashi Ogura
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.